ONO-7702 and ONO-7703 Expansion Study(ONO-7702/7703-02E)

ABSTRACT: Intervention name : Encorafenib, Binimetinib INN of the intervention : encorafenib, binimetinib Dosage And administration of the intervention : Encorafenib will be administered on a QD schedule and binimetinib will be administered on a BID schedule Control intervention name : - INN of the control intervention : - Dosage And administration of the control intervention : - Primary outcome(s): safety, efficacy - Study Design: A Multicenter, Single arm, Open-label Study

DISEASE(S): Braf V600e-mutant Metastatic Colorectal Cancer

PROVIDER: 2612052 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR